IsoRay, Inc. (NYSE American:ISR)

About the company

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

43

CEO

Lori A. Woods

Exchange

NYSE American

Website

http://www.isoray.com

$9.00M

Total Revenue

43

Employees

$42.21M

Market Capitalization

-12.60

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$5M

Operating Margin (in %)

Total operating margin

$-3M

Net Margin (in %)

Total net margin

$-3M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Catalent, Inc. CTLT 12377.43 2872.00 6.22 118.67 3.63
Horizon Therapeutics Plc HZNP 11924.85 1376.00 5.08 18.80 43.06
Perrigo Co. Plc PRGO 7959.70 4837.00 1.36 54.30 3.02
Bausch Health Cos., Inc. BHC 6583.45 8597.00 9.19 -3.48 -21.96
Jazz Pharmaceuticals Plc JAZZ 6239.22 2188.00 2.16 22.80 12.81
United Therapeutics Corp. UTHR 5208.59 1443.00 1.81 10.05 36.59
MyoKardia, Inc. MYOK 4337.34 34.00 12.61 -13.99 -201.73
Axsome Therapeutics, Inc. AXSM 2873.15 None 19.50 -31.94 None
Pacira Biosciences, Inc. PCRX 2414.16 435.00 6.47 -5748.00 -0.02
SAGE Therapeutics, Inc. SAGE 2353.00 9.00 2.77 -3.63 -413.06
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Prestige Consumer Healthcare, Inc. PBH 2006.85 963.00 1.69 14.15 14.77
Corcept Therapeutics, Inc. CORT 1984.94 335.00 4.56 18.70 31.64
Ironwood Pharmaceuticals, Inc. IRWD 1624.95 440.00 -23.00 19.17 19.14
Innoviva, Inc. INVA 1596.69 285.00 3.78 8.26 66.41
Madrigal Pharmaceuticals, Inc. MDGL 1558.95 0.00 4.16 -15.26 -624.74
Revolution Medicines, Inc. RVMD 1534.59 48.00 3.98 -21.68 -146.29
Intercept Pharmaceuticals, Inc. ICPT 1431.04 272.00 -42.59 -4.17 -127.53
Supernus Pharmaceuticals, Inc. SUPN 1346.76 402.00 2.14 11.55 28.90
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1321.20 5.00 3.61 -3.11 -241.62
Theravance Biopharma, Inc. TBPH 1255.14 88.00 -8.81 -5.09 -280.80
Revance Therapeutics, Inc. RVNC 1153.38 0.00 4.55 -6.18 41.82
Amphastar Pharmaceuticals, Inc. AMPH 996.17 327.00 2.49 19.55 15.90
BellRing Brands, Inc. BRBR 805.74 954.00 -0.44 6.11 13.98
Endo International Plc ENDP 775.20 3014.00 -1.06 -2.76 -9.09
Eagle Pharmaceuticals, Inc. EGRX 711.20 192.00 3.82 282.22 1.29
Assembly Biosciences, Inc. ASMB 684.40 16.00 3.07 -6.88 -601.75
Aerie Pharmaceuticals, Inc. AERI 632.04 79.00 5.01 -3.12 -252.92
Collegium Pharmaceutical, Inc. COLL 590.24 299.00 4.22 -45.68 -4.21
Intersect ENT, Inc. XENT 576.80 102.00 5.45 -11.55 -48.61
Catalyst Pharmaceuticals, Inc. CPRX 543.56 119.00 5.29 12.39 36.09
Anika Therapeutics, Inc. ANIK 529.20 125.00 1.83 19.09 22.73
BioDelivery Sciences International, Inc. BDSI 414.92 130.00 5.93 -56.38 -5.01
ANI Pharmaceuticals, Inc. ANIP 354.72 203.00 1.81 -227.38 -0.67
Albireo Pharma, Inc. ALBO 309.92 11.00 3.15 -4.05 -730.55
MEI Pharma, Inc. MEIP 290.50 5.00 5.00 -7.45 -539.48
Mallinckrodt Plc MNK 260.40 3037.00 0.14 -0.22 -39.56
Agile Therapeutics, Inc. AGRX 149.86 None 2.44 -7.26 None
Cerecor, Inc. CERC 118.68 7.00 7.59 -5.27 -429.22
Marinus Pharmaceuticals, Inc. MRNS 115.92 0.00 5.26 -1.72 None
Ampio Pharmaceuticals, Inc. AMPE 92.95 1.00 65.00 -5.00 None
AcelRx Pharmaceuticals, Inc. ACRX 86.40 2.00 -1.59 -1.54 -644.25
Evoke Pharma, Inc. EVOK 85.44 397.00 29.67 -12.71 -0.76
Aclaris Therapeutics, Inc. ACRS 83.23 4.00 1.46 -0.60 None
Zynerba Pharmaceuticals, Inc. ZYNE 81.88 0.00 1.34 -2.28 -699.94
CTI BioPharma Corp. CTIC 81.42 3.00 3.63 -1.97 -111.83
Oramed Pharmaceuticals, Inc. ORMP 77.14 3.00 2.80 -7.12 -398.34
Adamas Pharmaceuticals, Inc. ADMS 75.04 57.00 -4.79 -0.81 -160.44
Cassava Sciences, Inc. SAVA 64.41 41.00 3.39 -14.13 76.71
Acasti Pharma, Inc. ACST 58.65 0.00 4.93 -2.30 -611.47
Natural Alternatives International, Inc. NAII 50.26 114.00 0.69 -13.30 -3.19
Cumberland Pharmaceuticals, Inc. CPIX 49.35 47.00 1.00 -10.97 -9.59
SCYNEXIS, Inc. SCYX 46.92 0.00 9.86 -1.21 -30.84
IsoRay, Inc. ISR 42.21 9.00 7.87 -12.60 -36.08
Lipocine, Inc. LPCN 38.70 0.00 9.21 -2.58 None
Neos Therapeutics, Inc. NEOS 31.75 65.00 -2.44 -1.81 -26.74
PLx Pharma, Inc. PLXP 25.74 0.00 -2.47 -2.72 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.64 3.00 2.57 -1.74 -264.21
Regulus Therapeutics, Inc. RGLS 16.38 0.00 1.44 -0.76 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.66 -0.15 -798.18
Intec Pharma Ltd. NTEC 11.47 None 1.48 -0.26 None
Hepion Pharmaceuticals, Inc. HEPA 10.02 None 1.77 3.01 None
Sonoma Pharmaceuticals, Inc. SNOA 6.61 19.00 1.50 -3.32 -15.56
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 5.72 73.00 -0.13 -0.19 -39.28
Tonix Pharmaceuticals Holding Corp. TNXP 3.99 None 1.00 -0.08 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Isoray and University of Cincinnati Physicians Company Sign Research Agreement to Study Treatment of Head and Neck Cancers

29d ago, source: Stockhouse

RICHLAND, Wash., June 17, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR) today announced that it has entered into a research grant agreement with the University of Cincinnati Physicians ...

ISR IsoRay, Inc. Common Stock (DE)

1mon ago, source: Nasdaq

Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.

Radiation Therapy Market 2020 Would Face COVID-19 Challenges? Comprehensive Report | Hitachi, Nordion, Isoray, BD, IBA Worldwide, Accuray

27d ago, source: openpr.com

According to the report, The Insight Partners analysts predict the latest report on "Global Radiation Therapy Market (Covid-19) 2027 Impact and Analysis". The Radiation Therapy Market report ...

Isoray and University of Cincinnati Physicians Company Sign Research Agreement to Study Treatment of Head and Neck Cancers

29d ago, source: Benzinga.com

RICHLAND, Wash., June 17, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE:ISR) today announced that it has entered into a research grant agreement with the University of Cincinnati Physicians ...

IsoRay Inc.

27d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Isoray and University of Cincinnati Physicians Company Sign Research Agreement to Study Treatment of Head and Neck Cancers

29d ago, source: YAHOO!

RICHLAND, Wash., June 17, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR) today announced that it has entered into a research grant agreement with the University of Cincinnati ...

IsoRay Inc.

1mon ago, source: TheStreet.com

ISORAY INC's gross profit margin for the third quarter of its fiscal year 2020 has significantly increased when compared to the same period a year ago. The company grew its sales and net income ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.